Protect the unvaccinated, then offer boosters – WHO’s Ryan

DUBLIN: Getting an initial course of Covid-19 vaccines to unprotected groups all over the world should remain a top priority before offering booster shots to vulnerable groups, World Health Organisation (WHO) Emergency Director Mike Ryan said on Tuesday.

A major study on Tuesday found that two doses of Pfizer-BioNTech’s Covid-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, suggesting weaker efficacy against the new Omicron variant.

Ryan said he expected the current vaccines would provide significant protection against hospitalisation and death, but that the data coming through was very preliminary and the WHO did not have enough of it yet to make a full determination.

“People are always asking should we be going for a primary vaccination or boosters, the reality is we should be doing both,” Ryan told an online event.

“We should be focusing on getting those who are unvaccinated vaccinated as quickly as possible and then being able to give booster doses to those in vulnerable groups.”

Ryan said Omicron would most likely replace Delta as the globally dominant variant over time and that governments needed to refocus on basic protective measures such as mask wearing and make sure their hospitals were ready.

Even if Omicron turns out to be a milder disease in an individual patient, there was no doubt that the rapidly rising force of infection would generate more hospitalisations in the coming weeks just by the sheer weight of numbers, he added.

“Every single health system needs to get ready,” Ryan said. “We are going to likely to see a very large Omicron wave. We need to protect the health system, we need to protect those we love. It’s not rocket science, everyone knows how to do it.”

  • Related Posts

    • Pharma
    • June 27, 2025
    • 127 views
    Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

    Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners,…

    • Pharma
    • June 27, 2025
    • 113 views
    Sun Pharma ropes in Richard Ascroft as North America CEO

    Mumbai: Sun Pharma has announced the appointment of Richard Ascroft as the new North America (NAM) Chief Executive Officer (CEO). In a statement shared via LinkedIn, the company said, “We…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

    Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

    Sun Pharma ropes in Richard Ascroft as North America CEO

    Sun Pharma ropes in Richard Ascroft as North America CEO

    Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen

    Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen